Omalizumab Injection: Clinical Trials

5 trials of Omalizumab Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 2 Phase 4, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 1, Terminated 1
Phase 21Completed 1
Phase 31Completed 1

Follow Omalizumab Injection: new trials by email Literature Review of Omalizumab Injection trials Research Report on Omalizumab Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Omalizumab for Plant-Food Allergy Due to Sensitization to LTP or Profilin
Omalizumab Injection - Food Allergies
Not yet recruitingFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud372026-01-012025-08-12
Effect of Omalizumab in the Skin of Food Allergy Patients
Omalizumab Injection - Food Allergy, Food Allergy in Children
Phase 4RecruitingNational Jewish Health402024-10-012026-11-13
Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
Omalizumab Injection, Xolair Prefilled Syringe - Chronic Idiopathic Urticaria
Phase 3CompletedKashiv BioSciences, LLC6002023-08-152025-02-05
Protection From Food Induced Anaphylaxis by Reducing the Serum Level of Specific IgE (Protana).
Omalizumab Injection - Food Allergy
Phase 4TerminatedCarsten Bindslev-Jensen72019-07-012023-12-11
Treatment With the Anti-IgE Monoclonal Antibody Omalizumab in Women With Asthma Undergoing Fertility Treatment. - A Proof of Concept Study.
Omalizumab Injection, NaCl - Asthma, Infertility, Female
Phase 2CompletedCopenhagen University Hospital, Rigshospitalet662019-01-012025-04-08

Conditions studied

Food Hypersensitivity (3)  ·  Anaphylaxis (1)  ·  Asthma (1)  ·  Chronic Urticaria (1)  ·  Infertility, Female (1)

Sponsors

Carsten Bindslev-Jensen (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1)  ·  Kashiv BioSciences, LLC (1)  ·  National Jewish Health (1)

Countries

Denmark (2)  ·  United States (2)  ·  India (1)  ·  Jordan (1)

Top investigators

Carsten Bindslev-Jensen, ProfDrMedPhd (1)  ·  Charlotte G. Moertz, ProfMDPhd (1)

Results publications

PMID 33184076

NIH funding

2017 (1), 2018 (1)